Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Clear all

282 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20032
20042
20059
200611
20076
20088
200913
201017
201110
201215
201317
201416
20157
201615
20178
201811
201912
20208
202119
202216
202313
202414
202512
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed178
Terminated29
Recruiting26
Unknown status15
Withdrawn13
Not yet recruiting10
Active, not recruiting6
Enrolling by invitation3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
AstraZeneca8
GlaxoSmithKline8
Affymax7
Akebia Therapeutics7
Novartis Pharmaceuticals6
Boehringer Ingelheim5
Eli Lilly and Company5
Genzyme, a Sanofi Company5
Novo Nordisk A/S5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic282
Anemia48
Kidney Failure, Chronic32
Diabetes Mellitus, Type 225
Diabetic Nephropathies21
Kidney Diseases20
Renal Insufficiency18
Proteinuria17
Hypertension14
Cardiovascular Diseases10

Trials

Showing 51 to 75 of 282. Each trial links to its page on Pharma Observatory.

182 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.